Literature DB >> 19490981

Comparison of signal-to-cutoff values in first, second, and third generation enzyme immunoassays for the diagnosis of HTLV-1/2 infection in "at-risk" individuals from São Paulo, Brazil.

Fabrício Jacob1, Mariana C Magri, Emanuela A S Costa, Elizabeth Santos-Fortuna, Adele Caterino-de-Araujo.   

Abstract

Data obtained during routine diagnosis of human T-cell lymphotropic virus type 1 (HTLV-1) and 2 (HTLV-2) in "at-risk" individuals from São Paulo, Brazil using signal-to-cutoff (S/C) values obtained by first, second, and third generation enzyme immunoassay (EIA) kits, were compared. The highest S/C values were obtained with third generation EIA kits, but no correlation was detected between these values and specific antibody reactivity to HTLV-1, HTLV-2, or untyped HTLV (p=0.302). In addition, use of these third generation kits resulted in HTLV-1/2 false-positive samples. In contrast, first and second generation EIA kits showed high specificity, and the second generation EIA kits showed the highest efficiency, despite lower S/C values. Using first and second generation EIA kits, significant differences in specific antibody detection of HTLV-1, relative to HTLV-2 (p=0.019 for first generation and p<0.001 for second generation EIA kits) and relative to untyped HTLV (p=0.025 for first generation EIA kits), were observed. These results were explained by the composition and format of the assays. In addition, using receiver operating characteristics (ROC) analysis, a slight adjustment in cutoff values for third generation EIA kits improved their specificities and should be used when HTLV "at-risk" populations from this geographic area are to be evaluated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490981     DOI: 10.1016/j.jviromet.2009.03.024

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

1.  Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections.

Authors:  Gabriela de Melo Franco; Anderson Santos da Rocha; Laura Jorge Cox; Danielle Soares de Oliveira Daian E Silva; Débora Marques da Silveira E Santos; Marina Lobato Martins; Luis Claudio Romanelli; Ricardo Ishak; Antonio C R Vallinoto; Maria Rosa Q Bomfim; Adele Caterino-de-Araujo; Jordana G A Coelho-Dos-Reis; Flávio Guimarães da Fonseca; Edel Figueiredo Barbosa-Stancioli
Journal:  Front Public Health       Date:  2022-05-23

2.  Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil.

Authors:  Vanessa da Silva Brito; Fred Luciano Neves Santos; Noilson Lazaro Sousa Gonçalves; Thessika Hialla Almeida Araujo; Davi Silva Vale Nascimento; Felicidade Mota Pereira; Ney Cristian Amaral Boa-Sorte; Maria Fernanda Rios Grassi; Adele Caterino-de-Araujo; Bernardo Galvão-Castro
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

3.  Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).

Authors:  Karoline Rodrigues Campos; Maria Gisele Gonçalves; Nadia Aparecida Costa; Adele Caterino-de-Araujo
Journal:  Braz J Infect Dis       Date:  2017-03-24       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.